CA1339533C - T-butyl ergoline derivatives - Google Patents

T-butyl ergoline derivatives

Info

Publication number
CA1339533C
CA1339533C CA000540338A CA540338A CA1339533C CA 1339533 C CA1339533 C CA 1339533C CA 000540338 A CA000540338 A CA 000540338A CA 540338 A CA540338 A CA 540338A CA 1339533 C CA1339533 C CA 1339533C
Authority
CA
Canada
Prior art keywords
ergoline
group
pharmaceutically acceptable
hydrogen atom
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000540338A
Other languages
English (en)
French (fr)
Inventor
Maria Antonietta Cervini
Mauro Gobbini
Enzo Brambilla
Aldemio Temperilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of CA1339533C publication Critical patent/CA1339533C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Graft Or Block Polymers (AREA)
  • Developing Agents For Electrophotography (AREA)
CA000540338A 1986-06-25 1987-06-23 T-butyl ergoline derivatives Expired - Fee Related CA1339533C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8615471 1986-06-25
GB868615471A GB8615471D0 (en) 1986-06-25 1986-06-25 T-butyl ergoline derivatives

Publications (1)

Publication Number Publication Date
CA1339533C true CA1339533C (en) 1997-11-11

Family

ID=10600059

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000540338A Expired - Fee Related CA1339533C (en) 1986-06-25 1987-06-23 T-butyl ergoline derivatives

Country Status (20)

Country Link
US (2) US4843073A (da)
EP (1) EP0251652B1 (da)
JP (1) JPH0745498B2 (da)
KR (1) KR950008970B1 (da)
AT (1) ATE76407T1 (da)
AU (1) AU597672B2 (da)
CA (1) CA1339533C (da)
DE (1) DE3779190D1 (da)
DK (1) DK170099B1 (da)
ES (1) ES2042567T3 (da)
FI (1) FI85702C (da)
GB (1) GB8615471D0 (da)
GR (1) GR3005115T3 (da)
HU (1) HU196201B (da)
IE (1) IE61319B1 (da)
IL (1) IL82946A (da)
NZ (1) NZ220543A (da)
PT (1) PT85152B (da)
SU (1) SU1547708A3 (da)
ZA (1) ZA874569B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61245164A (ja) * 1985-04-23 1986-10-31 Seiko Instr & Electronics Ltd パタ−ン修正装置
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
WO2014195849A2 (en) * 2013-06-03 2014-12-11 Mahesh Kandula Compositions and methods for the treatment of cerebrovascular diseases

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228945A (en) * 1966-01-11 Methyl and i,g-dimethyl-b-(a-hydroxy- alkyl)-ergoline i derivatives
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
US3228942A (en) * 1966-01-11 Methyl and i,g-dimeti-iyl ergoline i compounds
DE203721C (da) * 1908-05-05
US3232942A (en) * 1964-06-02 1966-02-01 Sandoz Ltd 1-substituted (+)-lysergol
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
USRE30218E (en) * 1974-12-06 1980-02-19 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
GB2056437A (en) * 1979-08-07 1981-03-18 Erba Farmitalia Secoergoline derivatives
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3403067A1 (de) * 1984-01-30 1985-08-14 Eckart Prof. Dr. 6500 Mainz Eich Ergolin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
IT1213206B (it) * 1984-08-07 1989-12-14 Inverni Della Beffa Spa Procedimento per la preparazione di derivati del lisergolo.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
AU7914587A (en) * 1987-08-24 1989-03-31 Molecular Control Corporation Liquid crystal micelles, display, having concentric spheres

Also Published As

Publication number Publication date
AU7463287A (en) 1988-01-07
GR3005115T3 (da) 1993-05-24
DK322587A (da) 1987-12-26
ATE76407T1 (de) 1992-06-15
EP0251652A2 (en) 1988-01-07
DE3779190D1 (de) 1992-06-25
US4843073A (en) 1989-06-27
ZA874569B (en) 1988-02-24
PT85152A (en) 1987-07-01
DK322587D0 (da) 1987-06-24
FI85702B (fi) 1992-02-14
SU1547708A3 (ru) 1990-02-28
KR950008970B1 (ko) 1995-08-10
AU597672B2 (en) 1990-06-07
JPH0745498B2 (ja) 1995-05-17
HU196201B (en) 1988-10-28
US5079364A (en) 1992-01-07
JPS6322577A (ja) 1988-01-30
FI85702C (fi) 1992-05-25
PT85152B (pt) 1990-03-30
ES2042567T3 (es) 1993-12-16
FI872752A (fi) 1987-12-26
GB8615471D0 (en) 1986-07-30
IL82946A (en) 1991-04-15
EP0251652A3 (en) 1989-04-05
HUT44543A (en) 1988-03-28
IE61319B1 (en) 1994-11-02
EP0251652B1 (en) 1992-05-20
FI872752A0 (fi) 1987-06-22
NZ220543A (en) 1989-06-28
IL82946A0 (en) 1987-12-20
KR880000429A (ko) 1988-03-25
DK170099B1 (da) 1995-05-22
IE871652L (en) 1987-12-25

Similar Documents

Publication Publication Date Title
EP0266349B1 (de) Tricyclische indolderivate, herstellung und anwendung als arzneimittel
CS264295B2 (en) Process for preparing derivatives of 2-brom-alpha-ergo-cryptine
CA1339533C (en) T-butyl ergoline derivatives
US4213995A (en) 2-Phenylimino-imidazolidines and salts thereof
Manske et al. The alkaloids of papaveraceous plants: liv. The structure of eschscholtzine
KR950006866B1 (ko) 에르골린 에스테르의 제조방법
US4045443A (en) Organic compounds
EP0240986B1 (en) D-nor-7-ergoline derivatives, process for preparing them, pharmaceutical composition and use
GB2102801A (en) New bicyclic compounds of the general formula (i)
US4569945A (en) Diarylindane-1,3-diones, their preparation and use
US4123535A (en) Psychostimulating 14-amino-14,15-dihydroeburnamenines
US3280145A (en) New indole derivatives and their acid addition salts
US4730059A (en) 6'-thiomethylsubstituted spectinomycins
GB2106516A (en) Anthranilic acid esters
HU206215B (en) Process for producing 1-deoxy-15-doxo-1,15-epoxy-3-piperazinorifamycin derivatives and pharmaceutical compositions comprising same
US3330835A (en) Novel 1, 3, 4, 5-tetrahydropyrrolo [4, 3, 2-de] quinolines
CA1109864A (en) Ergoline derivatives
HU187733B (en) Process for preparing apovincaminic acid derivatives
GB2029405A (en) Brominated Derivatives of Vincamine
CA1194028A (en) Dibenz¬cd,f|indole derivatives, their preparation and pharmaceutical compositions containing them
US4061752A (en) 6-Piperazino-11-methylene-dibenzazepines[b,e]
US3246018A (en) 3beta-aminoandrost-5-ene-17beta-carboxylic acid and derivatives thereof
EP0014792B1 (en) Tetrahydro-2h-benzo(c)pyrroles, their preparation, pharmaceutical compositions containing them and the compounds for use as therapeuticals
Blondet et al. Convenient Synthesis of 6-Methyl, 8-Methyl and 6, 8-Dimethyl Derivatives of 5-Hydroxy-1, 2, 3, 4-Tetrahydro-2-Quinolinone
JPS5877869A (ja) 4−アミノ−2−ハロゲノピリミジン誘導体の製造方法

Legal Events

Date Code Title Description
MKLA Lapsed